Estro-Halt EU- Designed for Estrogen Support | Contains CDG, Indole-3-Carbinol & Apigenin

Product Information

Treatment of patients with cervical cancer in pregnancy should be exclusively done in gynecological oncology centers associated with the highest level perinatal center with expertise in all aspects of oncologic therapy in pregnancy and intensive medical care of premature neonates [V, A]. It is my great pleasure to invite you to ESTRO 2024 which will take place from 3 to 7 May in Glasgow, United Kingdom. Every patient diagnosed with cervical cancer in pregnancy must be counseled by a multidisciplinary team. This team should consist of experts in the fields of gynecological oncology, neonatology, obstetrics, pathology, anesthesiology, radiation oncology, medical oncology, psycho-oncology, and, spiritual and ethical counseling. National or international tumor board counseling may be considered [V, A]. Quantum Nutrition Labs is proud to offer a high-quality nutritional product line tomeet all the needs of you and your family. We provide a wide range of quantum-state nutritional formulas, including Quantum Estro Support . Our products are manufactured and diligently tested for identity, purity, strength, and nutrient content, as well as for potential contaminants such as pesticides, non-organic materials, and heavy metals including arsenic, mercury, cadmium and lead, that may negatively impact health. These ultra-quality products provide you with full confidence in our company ’s integrity that you can count on . . . day in and day out.

Last but not least, our offices are easily accessible by public transport and different training can be provided to meet a number of educational/development needs. This proprietary blend, available in a 3 oz bag, is an exclusive creation of The Smooth Generation LLC, meticulously formulated to provide holistic support for women's health and well-being. Equivocal extrauterine disease should be considered for biopsy to avoid inappropriate treatment [IV, B].Patients with cervical cancer should be staged according to the TNM classification and the International Federation of Gynaecology and Obstetrics (FIGO) staging should also be documented [IV, A]. Weight gain, severe mood swings, PMS symptoms and even gynecomastia ("man boobs") can be a result of xeno-estrogens or imbalances between estrogen and other hormones for both men and women. Loop or laser conization is preferable to cold-knife conization in women wanting to preserve fertility. Care should be taken to provide an intact (unfragmented) specimen with minimal thermal artifact. The cone specimen should be oriented for the pathologist [IV, B].

At the time of cesarean section, definitive cancer specific treatment should be performed corresponding to that of non-pregnant women, taking into account the treatment that has already been given during pregnancy [IV, A]. Adjuvant radiotherapy should be considered in the intermediate risk group (combination of risk factors at final pathology such as tumor size, LVSI, and depth of stromal invasion) [IV, A]. In case of suspected tumor persistence, recurrence or second primary cancer, histological verification is strongly recommended [V, A]. David Cibula, Maria Rosaria Raspollini, François Planchamp, Carlos Centeno, Cyrus Chargari, Ana Felix, Daniela Fischerova, Daniela Jahn-Kuch, Florence Joly, Christhardt Kohler, Sigurd F. Lax, Domenica Lorusso, Umesh Mahantshetty, Patrice Mathevet, Raj Naik, Remi Nout, Ana Oaknin, Fedro Peccatori, Jan Persson, Denis Querleu, Sandra Rubio, Maximilian Paul Schmid, Artem Stepanyan, Valentyn Svintsitskyi, Karl Tamussino, Ignacio Zapardiel, Jacob Christian Lindegaard.The use of whole-body diffusion-weighted imaging MRI (WB-DWI/MRI) can reliably obviate the need for gadolinium contrast and radiation for nodal and distant staging during pregnancy. If not available, chest CT scan with abdominal shielding is an alternative. PET-CT should be avoided during pregnancy [IV, B]. Delay of oncological treatment until fetal maturity (if possible >34 weeks of gestation) and initiate cancer-specific treatment immediately after delivery by cesarean section. This option might be considered if the term or fetal maturity is approaching.

ESTRO’s mission is to promote innovation, research, and dissemination of science through its congresses, special meetings, educational courses and publications. Job objectiveQuality of life and side effects should be regularly assessed at least by the physicians/clinical care nurses and if possible by patients (using patient related outcomes). Patient self-reporting of side effects should be encouraged during and after treatment with the same frequency as medical visits [IV, B]. Patients should be informed and educated at the time of diagnosis and throughout follow-up about signs/symptoms of recurrence. They should be informed about possible side effects (by physicians, nurses, brochures, videos, etc.) [V, A]. Networking with corporate partners is always invaluable. ESTRO 2024 will host Europe’s largest industry exhibition in radiation oncology. It will offer you a unique opportunity to interact with industry leaders and to find out about the latest developments in technology, techniques and oncology products.

Conization (with clear margins) alone or SH is an adequate treatment for patients with T1a2 disease [IV, B]. General recommendations for prescription of CTRT and IGBT are as follows (details given in the section on principles of radiotherapy) [III, B]: Amanda Webster (UK), Ben Slotman (NL), Daan Nevens (BE), Ester Hammond (UK), Ina Schulz-Jurgenliemk (NL), Jens Overgaard (DK), Ludvig Muren (DK), Ludwig Van den Berghe (BE), Marianne Aznar (UK), Michael Baumann (DE), Michelle Leech (IE), Pierre Blanchard (FR) Radical surgery or definitive CTRT according to the disease stage as recommended outside pregnancy, if the woman decides not to preserve the pregnancy. Pregnancy termination is recommended before any treatment after the first trimester, and fetus evacuation before CTRT, if possible.

Food to Support Healthy Aging

All data relevant to the study are included in the article or uploaded as supplementary information. After CTRT and BT, patients should be counseled about sexual rehabilitation measures including the use of vaginal dilators. Topical estrogens are indicated [IV, B].